AMANDA KEFFER: Open Payments
NPI 1346864105 · GREENSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,309 in 60 payments from 10 companies in 2025. Trend: 2023 $2,915 · 2024 $3,311 · 2025 $1,309
Food & beverage: $1,309
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 11 | $418 |
| Vanda Pharmaceuticals Inc. | 12 | $211 |
| ABBVIE INC. | 20 | $183 |
| Neurocrine BioSciences, Inc. | 2 | $154 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $88 |
| Alkermes, Inc. | 4 | $85 |
| Teva Pharmaceuticals USA, Inc. | 2 | $72 |
| Janssen Pharmaceuticals, Inc | 2 | $48 |
| Sage Therapeutics, LLC | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: Auvelity, VRAYLAR, INGREZZA, FANAPT, HETLIOZ, CAPLYTA, ARISTADA, UZEDY.
Industry payments across PA — which companies pay providers there.
